The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here:

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

About LP3

Lund Protein Production Platform (LP3) is a cross-faculty expert center and user facility of Lund University (LU). As such, we provide services and make equipment available in the areas of recombinant protein production, crystallisation, biophysical characterization, and structure determination.

Lund Protein Production Platform (LP3) harbours the LU node of a new national research infrastructure for protein production: Protein Production Sweden (PPS; external website) and is part of MAX IV FragMAX platform for X-ray-aided fragment screening (external website). In addition, LP3 provides the laboratories for the biological part of the Deuteration and Macromolecular Crystallization (DEMAX) platform of the European Spallation Source ERIC (ESS; external website) and closely collaborates with DEMAX. The service facility is integrated with research training and development of skills in experimental protein science for PhD students and postdocs. LP3 is also a part of SciLifeLab Lund (external homepage), cross-faculty initiative to bring researchers and infrastructures together.

LP3 is featured in EUGLOHRIA Talks and EUGLOHRIA Virtual Tours approaching audiences with interactive and innovative content strengthening the collaboration potential by featuring model core facilities. LP3 was identified as one of those infrastructures available to the Alliance. On the EUGLOHIA Talks homepage (external webpage) a video with an interview with the head of LP3, Dr. Wolfgang Knecht can be found, and it is also possible to take a virtual tour at LP3 on the EUGLOHRIA Virtual Tours website (external webpage).

LP3 encourage all researchers to follow the guidelines from the Swedish Research Council regarding good research practice including ethical considerations. PI’s are responsible for valid ethical approval of research studies.

For more information about LP3 please see Protein Production and Biophysics & Crystallisation.

Beyond LP3

For access to additional protein characterisation methods (CD, MS, NMR, and such) we can help you to get in contact with the appropriate experts. In Lund University Research Portal you find infrastructures in the university.

Surface plasmon resonance equipment (SPR and Biacore) is accessible at the IQ Biotechnology Platform (external website).

LP3 is engaged and affiliated in:


Protein Production Sweden (PPS – is funded by the Swedish Research Council as a national research infrastructure.

LP3 and the former crystallisation facility acknowledge past generous financial support from Lund University, Knut and Alice Wallenberg Foundation (SWEGENE programme), the Erik & Maja Lundqvist Foundation, the Carl Tesdorpf Foundation BioCARE (A Strategic Research Area at Lund University; external website) and the Swedish Research Council.

A house with the text Biologihuset written at the wall. Photo.

Contact information

Lund Protein Production Platform, LP3
Biology Building A, floor 1
Sölvegatan 35, Lund

Phone: +46 46 222 77 85
E-mail: lp3 [at] biol [dot] lu [dot] se

LP3 annual reports

For older annual reports, please contact us at lp3 [at] biol [dot] lu [dot] se.

Board of LP3

LP3 is governed by a board of one chair and 6 members, one each from the Faculty of Science, Faculty of Medicine, Faculty of Engineering, MAX IV and the European Spallation Source ERIC (external member) and one student. 

  • Prof. Susanna Horsefield (chair, Faculty of Science)
  • Prof. Ingemar André (Faculty of Science)
  • Dr. Kajsa Paulsson (Faculty of Medicine)
  • Prof. Mats Ohlin (Faculty of Engineering)
  • Dr. Kajsa Sigfridsson Clauss (MAX IV)
  • Dr. Sindra Petersson-Årsköld (European Spallation Source ERIC)
  • Student representative (elected by the student union)